Kidney disease ranges from mild dysfunction treatable with medication to severe cases requiring dialysis or transplant. Acute ...

Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire ...

After announcing successful trial results for its lead mRNA treatment earlier this year, Regulus Therapeutics agreed to be ...

Black men face higher mortality rates from hypertension, diabetes, and HIV/AIDS due to societal barriers, mistrust in ...

Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.

At univariable analysis, both anti-C1q antibodies and non-use of hydroxychloroquine predicted renal flares at baseline and 6 and 12 months. Proteinuria (24/h proteinuria and proteinuria 0.5 g/day or ...

Maze Therapeutics, Inc.’s MAZE share price has surged by 11.03%, which has investors questioning if this is right time to ...

The 24-year-old said the mix-up pushed his transplant wait time back anywhere from six months to a year due to all the tests ...

TRUMBULL, CONNECTICUT / / May 2, 2025 / ZetrOZ Systems and the Arthritis Foundation announce a partnership with the ...

Discover why boosting your potassium intake may be more effective for lowering blood pressure than simply cutting salt, plus ...

When put to the ultimate test, the vow “in sickness and in health” isn’t as strong as some couples might think − particularly if the wife is sick.

U.S. net product sales revenue for IBSRELA during the first quarter of 2025 was $44.4 million, reflecting significant year-over-year growth of approximately 57%. The strong growth was driven by ...